Ixazomib Impurity 63 CAS CATO-C4X-126763
| CAS No. | CATO-C4X-126763 |
| Molecular Formula | C14H21BN2O4 |
| Molecular Weight | 292.14 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Compared with other compounds in its class, the molecular weight of 292.14 g/mol gives Ixazomib Impurity 63 distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
Ixazomib Impurity 63 (CAS CATO-C4X-126763) is a certified pharmaceutical impurity reference standard with the molecular formula C14H21BN2O4 and a molecular weight of 292.14 g/mol.
Based on its molecular formula C14H21BN2O4, Ixazomib Impurity 63 contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 292.14 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Ixazomib Impurity 63 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C14H21BN2O4 |
| Molecular Weight | 292.14 g/mol |
| Appearance | Off-white to pale yellow crystalline powder |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 5.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 2 |
Related Ixazomib Standards
- Ixazomib Impurity 67 (CAS 1012-84-6)
- Ixazomib Impurity 37 (CAS CATO-C4X-126737)
- Ixazomib Impurity 38 (CAS CATO-C4X-126738)
- Ixazomib Impurity 39 (CAS CATO-C4X-126739)
- Ixazomib Impurity 21 (CAS CATO-C4X-126721)
- Ixazomib Impurity 23 (CAS CATO-C4X-126723)
- Ixazomib Impurity 41 (CAS CATO-C4X-126741)
- Ixazomib Impurity 88 (CAS CATO-C4X-126788)
Recommended Standards
- N-Methyl-1-(4-nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine (CAS 2096342-16-2)
- Crisaborole lmpurity 83 (CAS CATO-C4X-202183)
- Methyl 4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate (CAS 269410-10-8)
- Ethyl N-(4-bromophenyl)sulfonylformimidate (CAS 100981-68-8)
- Bisoprolol Impurity 78 (CAS 2226263-67-6)
- iphenhydramine Impurity 15 (CAS CATO-C4X-142415)
- Clopidogrel EP impurity D (CAS 1421283-60-4)
- 1-(5-Bromo-2-hydroxy-4-methoxyphenyl)ethanone (CAS 39503-61-2)
- Lysine Impurity 44 (CAS 73343-51-8)
- 3-([1,1'-Biphenyl]-4-yl(phenyl)phosphino)benzoic acid (CAS 62350-80-5)
- 2-Chloro-1-[1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-3,4-dihydro-2(1H)-isoquinolinyl]ethanone (CAS 730949-62-9)
- 4-(Difluoromethyl)-6-fluoro-2-methylnicotinoyl chloride (CAS 1806972-36-0)
- (S)-2-((S)-1-((Benzyloxy)carbonyl)-5-oxopyrrolidine-2-carboxamido)-4-methylpentanoic acid (CAS 71034-37-2)
- MLCK inhibitor peptide 18 (CAS 224579-74-2)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com